Sailing therapy sets sail for rare bone disease patients
NCT ID NCT07102875
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This pilot study tested whether a 5-day sailing therapy program followed by 3 months of home-based telerehabilitation is safe and feasible for young people aged 12–30 with rare skeletal disorders. 24 participants were randomly assigned to either the sailing-plus-rehab group or a rehab-only group. The study measured adherence, safety, motor function, and quality of life to see if this unique approach could improve both physical and emotional health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- sailing therapy and home-based telerehabilitation
- What this could lead to
- If successful, this could offer a new, engaging rehabilitation option that improves both physical function and emotional well-being for people with rare skeletal disorders.
- What could go wrong
- This is a small pilot study with only 24 participants, so results may not apply to everyone. The intervention is complex and may not be widely available or affordable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 30 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals aged 12 to 30 years, of any sex * Clinical and/or molecular genetic diagnosis of RSD per Orphanet classification * No orthopedic surgery within the past 6 months, unless deemed clinically irrelevant to study participation by the investigator * Ability to understand and comply with study procedures * Signed informed consent obtained from the participant or a legal guardian (for minors) Exclusion Criteria: * Severe or unstable medical conditions that could interfere with participation (e.g., uncontrolled cardiac or respiratory disease) * Cognitive or neurological impairments that may hinder adherence to the study protocol * Participation in similar intensive rehabilitation programs within the past 3 months * Contraindications to virtual or sailing-based activities, including but not limited to: (a) Severe motion sickness; (b) Vertigo or vestibular disorders; (c) Photosensitive epilepsy * Musculoskeletal injuries (e.g., fractures or major sprains) occurring within the past 12 months * Any condition or circumstance that, in the opinion of the investigator, may compromise safety or study compliance * Decline or inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rare bone disorders are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy, 40136, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.